作者: P. HILTON , S. L. STANTON
DOI: 10.1111/J.1464-410X.1982.TB06969.X
关键词:
摘要: Twenty-five patients complaining of nocturia completed a double-blind cross-over trial using desmopressin (DDAVP) and placebo. All had failed to respond treatment with antispasmodic agents evening fluid restriction. The drugs were given as single intranasal dose on retiring. Nocturnal urinary frequency was reduced from mean 3.2 episodes 2.6 placebo 1.9 DDAVP (0.01 greater than P 0.001). Diurnal symptoms not significantly affected side effects minimal. This drug seems have place in the nocturia, where more conventional therapies failed.